VistaPharm LLC Issues Voluntary Nationwide Recall of Sucralfate Oral Suspension, 1g/10mL Due to Microbial Contamination Identified as Bacillus Cereus
September 22, 2023 – Largo, Florida, VistaPharm LLC is voluntarily recalling one (1) lot of Sucralfate Oral Suspension, 1g/10mL, to the consumer level, due to Bacillus cereus contamination in the product.
Source: FDA Center for Drug Evaluation and Research - What's New - September 23, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Months after hospitalization for COVID-19, MRIs reveal multiorgan damage
This study found abnormal MRI results in 20% to 25% of both controls and hospitalized patients, suggesting “a lot of these cardiac abnormalities that were seen in the COVID group must have been there beforehand.” Post–COVID-19 patients with lingering cardiac symptoms might have disorders like heartbeat irregularities that aren’t always visible with MRI, or dysfunction in other organs, he adds. Although it can offer clues to an organ’s health, MRI is an imperfect measure of how a patient is faring after infection. Researchers found no connection between abnormal liver MRIs and symptoms such as gastroin...
Source: ScienceNOW - September 22, 2023 Category: Science Source Type: news

Hospital based injury and violence prevention programs : ATS Position Statement 2023 - American Trauma Society.
Injury and violence have a significant impact on the health and well-being of the U.S. population and are the leading cause of death for Americans ages 1 to 44.1 In 2021, 224,935 people were killed by unintentional injuries; an additional 48,183 persons di...
Source: SafetyLit - September 22, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

RSV Vaccine Given in Pregnancy to Help Shield Newborns Receives Full U.S. Approval
FRIDAY, Sept. 22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV). Following approval one month ago by the U.S. Food and Drug Administration, the Centers...
Source: Drugs.com - Daily MedNews - September 22, 2023 Category: General Medicine Source Type: news

Good Oral Health Linked to Improved Survival in Head & Neck Cancer
FRIDAY, Sept. 22, 2023 -- For patients with head and neck squamous cell carcinoma, good oral health is associated with improved survival, according to a study published online Sept. 19 in the Journal of the National Cancer Institute. Jason Tasoulas,...
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news

Morning Exercise May Be Best for Weight Management
FRIDAY, Sept. 22, 2023 -- Morning appears to be the best time of day to exercise for weight management, according to a study published online Sept. 4 in Obesity. Tongyu Ma, M.B.B.S., Ph.D., from Hong Kong Polytechnic University, and colleagues used...
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news

CMS: Medicaid Reinstated for Nearly 500,000 Children and Families
FRIDAY, Sept. 22, 2023 -- About 500,000 children and families have had their Medicaid reinstated after some states erroneously purged them because of a systems issue, the U.S. Centers for Medicare& Medicaid said Thursday. The agency had first...
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news

Ulike Celebrates a Decade of Innovation and Commitment to Cutting-Edge Beauty Technology
10 Years later and 4 Million Devices Sold Globally, Ulike Experiences Rapid Growth To The Top Of The IPL Hair Removal Market NEW YORK, Sept. 22, 2023 /PRNewswire-PRWeb/ -- Ulike, the global leader and pioneer of Sapphire IPL (Intense Pulsed Light) at-home hair removal, is celebrating a...
Source: PRWeb: Medical Pharmaceuticals - September 22, 2023 Category: Pharmaceuticals Tags: PDT Source Type: news

Kaiser Permanente names new president of Southern California and Hawaii
Michelle Gaskill-Hames has held this position on an interim basis since April.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2023 Category: Pharmaceuticals Authors: Kelsey Kukaua Medeiros Source Type: news

Rare disease research to find better treatments for millions fuelled by £1billion
EXCLUSIVE: Half a million people joined vital studies in five years, with research into neurological and respiratory conditions receiving the biggest boost.
Source: Daily Express - Health - September 22, 2023 Category: Consumer Health News Source Type: news

Three Antibiotic Regimens Show Similar Effectiveness for CAP Three Antibiotic Regimens Show Similar Effectiveness for CAP
Adults with nonsevere community-acquired pneumonia (CAP) responded nearly equally to three first-line and alternative antibiotic regimens, based on data from more than 23,000 individuals.MDedge News
Source: Medscape Medical News Headlines - September 22, 2023 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

How to build a habit in 5 steps, according to science
Using scientific research can help you be more successful at creating new habits and sticking to them.
Source: CNN.com - Health - September 22, 2023 Category: Consumer Health News Source Type: news

---
With so many symbols, rules and regulations, recycling is a complex topic. Many of us are making mistakes and contaminating tons of waste in the process. Learn some simple tips to help manage your trash better.
Source: CNN.com - Health - September 22, 2023 Category: Consumer Health News Source Type: news

Diligent Robotics scores $25M to scale ' socially-intelligent service robots '
The company will use the funds to expand its reach throughout hospitals in the U.S. and enhance product development.
Source: mobihealthnews - September 22, 2023 Category: Information Technology Source Type: news

Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
The global market for novel weight-loss drugs like Novo Nordisk A/S’s Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications. That’s according to BMO Capital Markets analyst Evan David Seigerman, who, in a note to clients late…#bmocapitalmarkets #evandavidseigerman #novonordiskswegovy #elilillyco #lilly
Source: Reuters: Health - September 22, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20